ARG1 Antibody (C-term) Blocking Peptide
€293.00
In stock
SKU
AC-BP8976b
Background:
Arginase catalyzes the hydrolysis of arginine to ornithine and urea. At least two isoforms of mammalian arginase exist (types I and II) which differ in their tissue distribution, subcellular localization, immunologic crossreactivity and physiologic function. The type I isoform encoded by this gene, is a cytosolic enzyme and expressed predominantly in the liver as a component of the urea cycle. Inherited deficiency of this enzyme results in argininemia, an autosomal recessive disorder characterized by hyperammonemia.
Other Names: Arginase-1, Liver-type arginase, Type I arginase, ARG1
Target/Specificity:
The synthetic peptide sequence used to generate the antibody AP8976b was selected from the C-term region of human ARG1. A 10 to 100 fold molar excess to antibody is recommended. Precise conditions should be optimized for a particular assay.
Type: Synthetic peptide
Primary Accession: P05089
Gene ID: 383
Gene Name: ARG1
Format: Synthetic peptide was lyophilized with 100% acetonitrile and is supplied as a powder. Reconstitute with 0.1 ml DI water for a final concentration of 1 mg/ml.
Bio References:
Haraguchi,Y., et.al., J. Clin. Invest. 86 (1), 347-350 (1990)
Arginase catalyzes the hydrolysis of arginine to ornithine and urea. At least two isoforms of mammalian arginase exist (types I and II) which differ in their tissue distribution, subcellular localization, immunologic crossreactivity and physiologic function. The type I isoform encoded by this gene, is a cytosolic enzyme and expressed predominantly in the liver as a component of the urea cycle. Inherited deficiency of this enzyme results in argininemia, an autosomal recessive disorder characterized by hyperammonemia.
Other Names: Arginase-1, Liver-type arginase, Type I arginase, ARG1
Target/Specificity:
The synthetic peptide sequence used to generate the antibody AP8976b was selected from the C-term region of human ARG1. A 10 to 100 fold molar excess to antibody is recommended. Precise conditions should be optimized for a particular assay.
Type: Synthetic peptide
Primary Accession: P05089
Gene ID: 383
Gene Name: ARG1
Format: Synthetic peptide was lyophilized with 100% acetonitrile and is supplied as a powder. Reconstitute with 0.1 ml DI water for a final concentration of 1 mg/ml.
Bio References:
Haraguchi,Y., et.al., J. Clin. Invest. 86 (1), 347-350 (1990)
| Is Featured? | No |
|---|
Write Your Own Review